COGT (Cogent Biosciences) Interest Expense: $-4.28 Mil (TTM As of Mar. 2026)


COGT Cogent Biosciences Inc COGT
25 GF Score
Price $38.19
! 5 Warning Signs
View Full Analysis

What is Cogent Biosciences Interest Expense?

Cogent Biosciences COGT +0.37% 25 Interest Expense is $-4.28 Mil as of Mar. 2026. GuruFocus rates COGT with a GF Score™ of 25/100. The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cogent Biosciences's interest expense for the three months ended in Mar. 2026 was $ -1.21 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-4.28 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cogent Biosciences's Operating Income for the three months ended in Mar. 2026 was $ -103.61 Mil. Cogent Biosciences's Interest Expense for the three months ended in Mar. 2026 was $ -1.21 Mil. Cogent Biosciences did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cogent Biosciences  (NAS:COGT) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cogent Biosciences's Interest Expense for the three months ended in Mar. 2026 was $-1.21 Mil. Its Operating Income for the three months ended in Mar. 2026 was $-103.61 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $237.27 Mil.

Cogent Biosciences's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Cogent Biosciences did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Cogent Biosciences Interest Expense Historical Data

* Premium members only.

The historical data trend for Cogent Biosciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cogent Biosciences Interest Expense Chart

Cogent Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -3.06

Cogent Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.31 -1.46 -1.29 -1.21
COGT
25GF Score
Cogent Biosciences Inc COGT
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cogent Biosciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-4.28 Mil mean?
Cogent Biosciences (COGT) has a Interest Expense of $-4.28 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Cogent Biosciences and its competitors.
Is Cogent Biosciences' Interest Expense too high?
Cogent Biosciences' current Interest Expense is $-4.28 Mil. Overall, Cogent Biosciences has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Cogent Biosciences' Interest Expense compare to SRRK and CGON?
Cogent Biosciences' Interest Expense of $-4.28 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Cogent Biosciences and its competitors. Cogent Biosciences's current Interest Expense is $-4.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogent Biosciences stock overvalued right now?
Cogent Biosciences (COGT) has a current Interest Expense of $-4.28 Mil. The current Interest Expense is $-4.28 Mil. Cogent Biosciences' overall GF Score™ is 25/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Cogent Biosciences (COGT), the current Interest Expense is $-4.28 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cogent Biosciences Business Description

Address 275 Wyman Street, 3rd Floor, Waltham, MA, USA, 02451
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
25GF Score

Get the complete analysis for COGT

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$38.19
Price